South Denver Cardiologists image

Current Studies

 

Study Type: STATIN INTOLERANT – CLEAR
Overview: This study will evaluate whether administration of bempedoic acid 180 mg/day versus placebo reduces the risk of major adverse cardiovascular events (MACE) in patients with, or at high risk for, cardiovascular disease who are statin intolerant. About 12,604 patients will be randomized 1:1 to receive either bempedoic acid or placebo.
Goal of the study:  Candidates need to be intolerant to 1 or more different statins, intolerant due to an adverse safety effect that started or increased during statin therapy and resolved or improved when statin therapy was discontinued.

 

Study Type: HEART FAILURE – EMPEROR 1245
Overview: Two studies to evaluate the efficacy and safety of once-daily empagliflozin 10 mg compared to placebo, in patients with chronic Heart Failure with preserved Ejection Fraction (HFpEF). 
Goal of the study: The goal of this event-driven trial is to demonstrate the superiority of empagliflozin 10 mg compared to placebo in patients with symptomatic, chronic heart failure with preserved ejection fraction (LVEF > 40%) under stable treatment of heart failure symptoms.

 

Study Type: HEART FAILURE – GALACTIC
Overview: A Study to Assess the Efficacy and Safety of Omecamtiv Mecarbil on Mortality and Morbidity in Subjects with Chronic Heart Failure with Reduced Ejection Fraction
Goal of the study: To evaluate the effects of treatment with Omecamtiv Mecarbil (OM) compared with placebo on the time to cardiovascular (CV) death, or first heart failure event in subjects with chronic heart failure with reduced ejection fraction receiving standard of care therapy.

 

 Study Type: 
 Overview: 
 Goal of the study: 

 

 Study Type: 
 Overview: 
Goal of the Study:

 

 Study Type:
 Overview: 
 Goal of the study:  

 

Study Type: 
Overview: 
Goal of the study:  

 

Study Type:
Overview:
Goal of the study:

 

If you are interested in participating in or learning more about our research program, please ask your cardiologist or call 303-744-1065 and ask for the research department.